Mapping Sound Propagation Through the Human Lung for Better Diagnosis
NCT ID: NCT03043898
Last Updated: 2020-11-05
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
62 participants
OBSERVATIONAL
2018-02-14
2020-04-23
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The methodology of the study will be to place a sound source at a known location in the chest and measure the acoustic response on the posterior chest wall with an acoustic sensor array.
The sound source will be created by playing sound down the working channel of a bronchoscope and located anatomically using direct imaging.
Subjects will be selected for the study by asking patients undergoing a bronchoscopy procedure whether they would be willing to take part in the experiment in addition to their standard procedure.
Procedures will take place in the Bronchoscopy Unit at Addenbrooke's hospital in Cambridge. The Unit runs regional speciality clinics in severe chronic obstructive pulmonary disease, asthma, lung cancer, bronchomalacia and interstitial lung disease and has a nationally significant interventional bronchoscopy service.
A subsidiary part of the study (Part A) will collect sound recordings from healthy volunteers and patients with common respiratory diseases using the same acoustic sensor array. This is to create a database of lung sounds and quantify inter-subject variability.
The study will last approximately 30 months.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
In Part A, healthy volunteers and patients at Addenbrooke's hospital will have the chest sounds at their back recorded using an electronic-stethoscope array. This will be done in a single session lasting approximately 30 minutes. 50 healthy volunteers and 100 patients will be included.
In Part B, 50 patients undergoing a bronchoscopy at Addenbrooke's hospital will have their bronchoscopy extended by 5-10 minutes so that sounds can be played through the working channel of the bronchoscope and recorded by a microphone array at the posterior chest. Part B will investigate 25 patients with structurally 'normal' lungs (for example patients with Chronic Cough) (Part B(i)), and 25 patients with lung disease that has resulted in an 'abnormal' lung structure (Part B(ii)).
The consultant bronchoscopist will assign the patient to the relevant group based on information from their medical history and their CT scan. For Part B of the study an existing CT scan is an inclusion criterion. CT scans will not be carried out specifically for this study.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Part A(i) Healthy Volunteers
50 healthy volunteers. Intervention: Lung sound recording for part A(i) of the study.
Lung sound recording
Lung sounds are recorded using a sensor array.
Part A(ii) Patients
100 patients with wheezing and/or crackles due to respiratory disease. Intervention: Lung sound recording for part A(ii) of the study.
Lung sound recording
Lung sounds are recorded using a sensor array.
Part B(i) 'normal' lung structure
25 patients who are scheduled to have a Bronchoscopy as part of their standard care and are identified by a medical professional as having a 'normal' lung structure.
Intervention: Lung sound transmission measurement for part B(i) of the study.
Lung sound transmission measurement
Sound at chest wall is recorded using a sensor array during the bronchoscopy procedure, while a sound is played down the working channel of the bronchoscope.
Part B(ii) 'abnormal' lung structure
25 patients who are scheduled to have a Bronchoscopy as part of their standard care and are identified by a medical professional as having an 'abnormal' lung structure.
Intervention: Lung sound transmission measurement for part B(ii) of the study.
Lung sound transmission measurement
Sound at chest wall is recorded using a sensor array during the bronchoscopy procedure, while a sound is played down the working channel of the bronchoscope.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Lung sound transmission measurement
Sound at chest wall is recorded using a sensor array during the bronchoscopy procedure, while a sound is played down the working channel of the bronchoscope.
Lung sound recording
Lung sounds are recorded using a sensor array.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Male of Female, aged 18 years or above.
* Part A(i) Healthy volunteer with no history of smoking, recreational drug use or respiratory disease.
* Part A(ii) Patient admitted to Addenbrooke's with a pulmonary disease resulting in crackles and/or wheezes (as diagnosed by a qualified medical practitioner).
* Part B Patient admitted to Addenbrooke's hospital for a bronchoscopy procedure.
* Part B Appropriate recent imaging available: chest CT within 3 months.
* Part B(i) Lung structure deemed 'normal' by pulmonary physician based on CT scan and medical history.
* Part B(i) Lung structure deemed 'abnormal' by pulmonary physician based on CT scan and medical history.
Exclusion Criteria
* Subject is under 18 years old.
* WHO performance status \>2.
* Subject is pregnant.
* Subject is unable to understand English.
* Part A(i) History of smoking, recreational drug use or respiratory disease.
* Part A(ii) Condition judged to have no effect on breathing sounds. Patient with crackle or wheeze when quota for crackle or wheeze patients respectively is fulfilled.
* Part B Risk associated with prolonging bronchoscopy procedure judged to be too high by medical professional.
* Part B Appropriate recent imaging (chest CT within 3 months) not available.
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Cambridge University Hospitals NHS Foundation Trust
OTHER
Maximilian Nussbaumer
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Maximilian Nussbaumer
Principal Researcher
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Pasupathy Sivasothy, PhD
Role: PRINCIPAL_INVESTIGATOR
Cambridge University Hospitals NHS Foundation Trust
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Cambridge University Hospitals and the University of Cambridge
Cambridge, , United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
A093684
Identifier Type: -
Identifier Source: org_study_id